Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-07

FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved Sandoz's supplemental application for tacrolimus, making a generic tacrolimus product available for preventing organ transplant rejection. The prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)